Hyperprolactinemia and Pituitary Dysfunction

Hyperprolactinemia is an elevated serum prolactin concentration that can disrupt the reproductive axis and cause oligomenorrhea, amenorrhea, galactorrhea, and anovulatory infertility. It is a leading pituitary cause of ovulatory dysfunction, frequently due to a prolactin-secreting pituitary adenoma (prolactinoma) but also to physiological, pharmacologic, and other causes.

Definition

Hyperprolactinemia is a sustained elevation of serum prolactin above the reference range; when it suppresses gonadotropin-releasing hormone secretion it produces hypogonadotropic anovulation, and the most common pathological cause is a prolactin-secreting pituitary adenoma.

Scope

This topic covers the causes of elevated prolactin, the mechanism by which prolactin excess suppresses ovulation, the clinical presentations, and the principles of evaluation including exclusion of physiological and drug-related causes. It is a reference overview, not a treatment guide.

Core questions

• By what mechanism does excess prolactin suppress ovulation?
• How are physiological, pharmacologic, and pathological causes of hyperprolactinemia distinguished?
• When does the pattern of prolactin elevation point toward a prolactinoma versus other causes?

Key concepts

• Prolactin and suppression of GnRH pulsatility
• Prolactinoma (micro- and macroadenoma)
• Physiological hyperprolactinemia (pregnancy, lactation, stress)
• Drug-induced hyperprolactinemia
• Macroprolactin and assay interference
• Galactorrhea and hypogonadism
• Dopaminergic regulation of prolactin

Mechanisms

Prolactin secretion from the anterior pituitary is under tonic inhibitory control by hypothalamic dopamine. When prolactin is elevated — by an autonomously secreting adenoma, by loss of dopaminergic inhibition, by drugs that block dopamine, or by physiological states such as pregnancy — it suppresses the pulsatile secretion of gonadotropin-releasing hormone. The resulting fall in LH and FSH impairs follicular development and ovulation, producing menstrual disturbance and anovulatory infertility, and the lactotroph stimulation can also cause galactorrhea. Distinguishing pathological elevation from physiological causes, drug effects, and assay artefacts such as macroprolactin is central to evaluation.

Clinical relevance

Hyperprolactinemia is a recognized and often treatable pituitary cause of anovulation, so it is routinely considered in the workup of menstrual irregularity and subfertility. This entry explains the condition for educational orientation and does not provide diagnostic thresholds or treatment recommendations for individuals.

Epidemiology

Prolactinomas are the most common functioning pituitary tumors, and hyperprolactinemia from all causes is a frequent finding in women presenting with oligomenorrhea, amenorrhea, or galactorrhea; drug-induced elevation is also common where dopamine-blocking medications are used.

History

The role of prolactin in human reproduction was clarified after the hormone was distinguished from growth hormone in the 1970s, and the recognition that prolactin excess suppresses gonadotropin secretion led to its inclusion among the principal pituitary causes of anovulation. Evidence-based assessment was later codified in clinical practice guidelines such as the 2011 Endocrine Society guideline.

Key figures

• Shlomo Melmed

Seminal works

• melmed-2011

Frequently asked questions

Why does high prolactin stop ovulation?

Elevated prolactin suppresses pulsatile gonadotropin-releasing hormone secretion, lowering LH and FSH so that follicles do not mature and ovulation does not occur.

What is the most common pathological cause of hyperprolactinemia?

A prolactin-secreting pituitary adenoma, or prolactinoma, is the most common pathological cause; physiological states, medications, and assay artefacts such as macroprolactin must also be considered.